<?xml version="1.0" encoding="UTF-8"?>
<p id="p0130">The upper and lower respiratory tract may have different requirements for IFN-λ. As opposed to in the lung (lower respiratory tract) where the activities of IFN-α and -λ overlap, only IFN-λ offers critical protection in the upper respiratory tract in mice (
 <xref rid="bib29" ref-type="bibr">Klinkhammer et al., 2018</xref>). When viruses were delivered specifically to the upper airway at a lower dose to closely mimic a natural respiratory viral infection, IFN-λ was required for preventing IAV spread to the lung. Moreover, 
 <italic>Ifnlr1</italic>
 <sup>−/−</sup> mice shed more infectious viral particles and caused more frequent virus transmission to naive contacts than wild-type or 
 <italic>Ifnar1</italic>
 <sup>−/−</sup> mice (
 <xref rid="bib29" ref-type="bibr">Klinkhammer et al., 2018</xref>). Whereas prophylactic intranasal administration of either IFN-α or IFN-λ blocked IAV replication in the lung, only IFN-λ conferred long-lasting antiviral protection in the upper airway and limited contact virus transmission (
 <xref rid="bib29" ref-type="bibr">Klinkhammer et al., 2018</xref>).
</p>
